Goods and services:

History and publication details:

1) Date: 2026-02-24
Display name: Adverse Report (Examination) correspondence sent
2) Date: 2026-02-24
Display name: IP Right has been Examined
3) Date: 2026-02-24
Display name: Examination Response Received
4) Date: 2026-01-28
Display name: IP Right Amendment Made correspondence sent
5) Date: 2026-01-28
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:9; 35
Previous details: Class Count: 2 Class Numbers: 9; 35
New details: Class Count: 2 Class Numbers: 9; 35
6) Date: 2026-01-28
Display name: IP Right Goods and Services Items updated
Description: Class Number: 9
Previous details: Class Number: 9 Class Items: Downloadable data sets, reports, analyses, and publications in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, analyses, and publications in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs; Business and commercial pharmaceutical market analysis and information services; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets; Business information tracking and market analysis services in the field of pharmaceuticals; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing financial and insurance information, data, and analytics in the field of pharmaceuticals and pharmaceutical markets; Financial and insurance information tracking and analysis services in the field of pharmaceutical markets; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) featuring computer software platforms for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics regarding pharmaceuticals; Scientific and scientific research information tracking and analysis services in the field of pharmaceuticals; Software as a service (SAAS) featuring software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals; Medical, therapeutic, pharmacological, and pharmaceutical information, analytics, and data services; Medical, therapeutic, pharmacological, and pharmaceutical information and information analysis services; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Pharmaceutical information tracking and analysis services
New details: Class Number: 9 Class Items: Downloadable data sets, reports, analyses, and publications in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, analyses, and publications in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs; Business and commercial pharmaceutical market analysis and information services; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets; Business information tracking and market analysis services in the field of pharmaceuticals; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing financial and insurance information, data, and analytics in the field of pharmaceuticals and pharmaceutical markets; Financial and insurance information tracking and analysis services in the field of pharmaceutical markets; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) namely, computer software platforms for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics regarding pharmaceuticals; Scientific and scientific research information tracking and analysis services in the field of pharmaceuticals; Software as a service (SAAS) namely, software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals; Medical, therapeutic, pharmacological, and pharmaceutical information, analytics, and data services; Medical, therapeutic, pharmacological, and pharmaceutical information and information analysis services; Information, analytics, and data services, namely, gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Pharmaceutical information tracking and analysis services
7) Date: 2026-01-27
Display name: IP Right Amendment Requested
8) Date: 2024-09-19
Display name: General Correspondence sent
9) Date: 2024-09-19
Display name: Deferment of Acceptance
Description: Deferral Period: Until the reason for the deferral is resolved Time remaining to accept: 443 days Reasons for deferral: Awaiting finalisation of a similar trade mark;
Previous details:
New details:
10) Date: 2024-09-17
Display name: Deferral of Acceptance Requested
11) Date: 2024-09-05
Display name: Adverse Report (Examination) correspondence sent
12) Date: 2024-09-05
Display name: IP Right has been Examined
13) Date: 2024-04-24
Display name: Adverse Report (Examination) correspondence sent
14) Date: 2024-04-24
Display name: IP Right has been Examined
15) Date: 2024-04-24
Display name: Examination expedited
16) Date: 2024-04-24
Display name: Awaiting examination
17) Date: 2024-04-18
Display name: IP Right Filed correspondence sent
18) Date: 2024-04-18
Display name: IP Right Filed Published
19) Date: 2024-04-18
Display name: Status change to Published
20) Date: 2024-04-18
Display name: Status change to Filed
21) Date: 2024-04-18
Display name: Minimum Filing Requirements Considered
22) Date: 2024-04-18
Display name: Status change to Received
23) Date: 2024-04-18
Display name: Trade mark representation updated
24) Date: 2024-04-18
Display name: Application Received